EI
AZN icon

Ellevest Inc’s AstraZeneca AZN Stock Holding History

Ellevest Inc’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.14M Buy
5,758
+1,310
+29% +$253K 0.16% 89
2025
Q4 		$818K Buy
4,448
+18
+0.4% +$3.16K 0.11% 130
2025
Q3 		$680K Buy
4,430
+22
+0.5% +$3.33K 0.1% 155
2025
Q2 		$616K Sell
4,408
-354
-7% -$49.6K 0.1% 155
2025
Q1 		$700K Sell
4,762
-3,285
-41% -$475K 0.05% 147
2024
Q4 		$1.05M Sell
8,047
-2,540
-24% -$356K 0.06% 99
2024
Q3 		$1.65M Sell
10,587
-436
-4% -$70.4K 0.09% 67
2024
Q2 		$1.72M Buy
11,023
+2,172
+25% +$327K 0.1% 58
2024
Q1 		$1.2M Buy
8,851
+921
+12% +$122K 0.07% 80
2023
Q4 		$1.07M Sell
7,930
-265
-3% -$34.4K 0.07% 78
2023
Q3 		$1.11M Buy
8,195
+676
+9% +$92.3K 0.09% 62
2023
Q2 		$1.08M Buy
7,519
+143
+2% +$21K 0.08% 64
2023
Q1 		$1.02M Buy
7,376
+200
+3% +$26.9K 0.08% 63
2022
Q4 		$973K Buy
7,176
+1,115
+18% +$140K 0.08% 58
2022
Q3 		$665K Sell
6,061
-1,585
-21% -$201K 0.06% 72
2022
Q2 		$1.01M Buy
7,646
+615
+9% +$80.7K 0.09% 49
2022
Q1 		$933K Buy
7,031
+1,808
+35% +$217K 0.08% 59
2021
Q4 		$608K Sell
5,223
-388
-7% -$45.7K 0.05% 80
2021
Q3 		$674K Buy
5,611
+1,200
+27% +$140K 0.07% 73
2021
Q2 		$528K Buy
4,411
+1,140
+35% +$125K 0.05% 84
2021
Q1 		$325K Buy
3,271
+531
+19% +$53.4K 0.04% 117
2020
Q4 		$274K Buy
2,740
+558
+26% +$59.1K 0.04% 117
2020
Q3 		$239K Buy
2,182
+431
+25% +$47.9K 0.04% 114
2020
Q2 		$185K Buy
1,751
+662
+61% +$68.4K 0.04% 122
2020
Q1 		$97K Buy
1,089
+532
+96% +$50.1K 0.03% 143
2019
Q4 		$56K Buy
557
+432
+346% +$40.7K 0.02% 162
2019
Q3 		$11K Buy
125
+7
+6% +$607 ﹤0.01% 220
2019
Q2 		$10K Buy
+118
New +$9.25K ﹤0.01% 250

Other funds holding AZN

IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VAM
Vanguard Asset Management London, Ec4n 8af $117B AUM

Ellevest Inc's AZN Position: Q1 2026 in Review

Ellevest Inc increased its AstraZeneca (AZN) stake by 29% in Q1 2026, buying an estimated $253K and bringing the position to 5,758 shares worth $1.14M. The position accounts for 0.16% of the portfolio, ranked #89.

Ellevest Inc first reported a position in AZN in Q2 2019 and has held it in 28 quarters since. The position peaked at $1.72M in Q2 2024. 1,378 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

  • Ellevest Inc held 5,758 shares of AstraZeneca worth $1.14M as of Q1 2026.
  • Ellevest Inc bought 1,310 AstraZeneca shares in Q1 2026, an estimated $253K.
  • AstraZeneca made up 0.16% of Ellevest Inc's portfolio in Q1 2026, its #89 holding.
  • Ellevest Inc first reported a position in AstraZeneca in Q2 2019 and has held it in 28 quarters since.
  • Ellevest Inc's AstraZeneca position peaked at $1.72M in Q2 2024.
  • 1,378 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on Ellevest Inc's 13F filing for Q1 2026, filed 11 May 2026.